Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘psychiatry’ Category

Publisher flags paper on same-sex parenting after neo-Nazi group cites it

with 15 comments

A publisher has issued an expression of concern (EoC) about a study that claimed children with same-sex parents were at greater risk of depression and abuse, after posters using statistics from the paper to support a homophobic message appeared in Australia and the US.

On Aug. 21, several news websites reported that these posters were appearing in Melbourne, Australia, citing claims from a 2016 paper published in Depression Research and Treatment, which said that children with same-sex parents are more at risk for depression, abuse, and obesity than children with opposite-sex parents. The poster had also appeared previously in Minneapolis and has been traced to a neo-Nazi group, as reported by HuffPost Australia. Australia is preparing for a national, non-binding, mail-in vote on whether to provide marriage equality for same-sex couples.

The EoC mechanism, which was chosen by the journal’s publisher, Hindawi, is an unusual choice here. The paper’s author, D. Paul Sullins, a sociology professor at The Catholic University of America and the paper’s author, told Retraction Watch that Hindawi contacted him Aug. 21 about the decision. Initially, he told us he didn’t have any “particular objection to it,” but later told us he changed his mind after he read more about COPE’s guidelines for EoCs: Read the rest of this entry »

Written by Andrew P. Han

August 25th, 2017 at 11:53 am

Uni dings schizophrenia studies for problems with informed consent, other flaws

without comments

Psychiatry journals have retracted two papers evaluating a schizophrenia drug after a university in Japan flagged issues, such as a lack of written informed consent.

The papers—published in Human Psychopharmacology: Clinical & Experimental in 2012 and Psychiatry and Clinical Neurosciences in 2014—examined the safety and effectiveness of an antipsychotic drug in patients with schizophrenia.

According to the retraction notice in Psychiatry and Clinical Neurosciences, the ethics committee at St. Marianna University School of Medicine in Kawasaki found that “the trial included subjects who did not satisfy inclusion criteria.” For instance, not all patients provided written informed consent. But the university found no evidence for data falsification or fabrication.

A spokesperson for Human Psychopharmacology told us: Read the rest of this entry »

NIH neuroscientist up to 19 retractions

with 5 comments

Stanley Rapoport.
Source: NIH

The string of apparent bad luck continues for Stanley Rapoport.

Rapoport, a neuroscientist based at the U.S. National Institute on Aging, has lost three more papers in three journals due to the misconduct of his co-authors. By our count, these retractions bring his tally to 19 — and tie him for 21st place on our leaderboard.

The journals—Schizophrenia Research, Journal of Affective Disorders, and Biological Psychiatry— retracted the papers because the National Institutes of Health had found that one of Rapoport’s co-authors, Jagadeesh Rao, had “engaged in research misconduct by falsifying data.” Rao was corresponding author on all three papers.

According to a spokesperson for Elsevier, which publishes the journals, the Schizophrenia Research paper was retracted in July, the JAD paper in late May and the Biological Psychiatry paper in late April. The spokesperson told us that the publisher first received an email from the NIH about the misconduct findings on September 20, 2016, and that: Read the rest of this entry »

Ex-researcher who shot dean found guilty of attempted murder

with 19 comments

Hengjun Chao Credit: Westchester County DA

 

A New York jury has found Hengjun Chao, a former research assistant professor at Mount Sinai, guilty of attempted second degree murder and two other charges.

Last year, Chao shot Dennis Charney, a Mount Sinai dean who had fired him in 2010 for misconduct, outside of a deli in a wealthy New York suburb. After the incident, Chao admitted to police he shot Charney. During the trial, Chao’s lawyer argued that Chao had done so to draw attention to what he believed to be misconduct at Mount Sinai.

As reported by the Chappaqua Patch, in addition to one count of attempted second degree murder, Chao was convicted of one count of criminal use of a firearm and one count of assault. He faces a maximum of 25 years in state prison.

Chao’s attorney, Stewart Orden, told Retraction Watch:

Read the rest of this entry »

Written by Andrew P. Han

June 14th, 2017 at 12:12 pm

Prominent NIH researcher up to a dozen retractions

with 10 comments

Stanley Rapoport. Source: NIH

Neuroscientist Stanley Rapoport hasn’t had much luck with his co-authors.

Recently, we’ve reported on multiple retractions of papers co-authored by Rapoport after three different first authors were found to have committed misconduct. Now, the fallout from one of those cases had led to four more retractions, bringing Rapoport’s total to 12.

The latest batch of retractions stem from the actions of Jagadeesh Rao.

Here’s the first notice, issued by Psychopharmacology:

Read the rest of this entry »

When does animal research become unnecessary and cruel? A paper’s methods give a biologist pause

with 16 comments

Elies Bik

Microbiologist Elies Bik is well-known for applying a close eye to studies, and has spent years anonymously submitting reports on plagiarism and image duplication to journal editors. Last year, she published an analysis of work, with troubling results – that 1 in 25 biomedical papers contains inappropriate duplications in images. She’s never stopped reading papers closely, and recently flagged one on Twitter for concerns about its methodology. Although Bik is not against animal research, she said the treatments rats faced in the paper made her queasy – and didn’t seem justified. She explains her reasoning below.

Read the rest of this entry »

Written by Alison McCook

February 28th, 2017 at 11:45 am

Study errors “may have placed you or your child at a greater risk of harm”: 2014 letter to parents

with 6 comments

Mani Pavuluri

Mani Pavuluri

Three psychiatric studies of children contained a myriad of problems that may have put participants at greater risk than was disclosed by consent forms, according to a 2014 letter sent to hundreds of the participants and their families.

Through a public records request, we’ve obtained a copy of the letter — which lists a host of problems in the studies, ranging from enrolling ineligible patients, not informing families of the risks associated with the studies, and skipping tests intended to minimize the risks associated with lithium.

In 2013, Mani Pavuluri told the University of Illinois at Chicago that one of her study participants had been hospitalized — an event which prompted the university to halt three of her studies, launch a misconduct probe, and send letters to approximately 350 families of children participating in the research, notifying them of what happened.

The letter concludes:

Read the rest of this entry »

A grad student was caught in the crossfire of fraud — and fought back

with 16 comments

uqIn March, 2013, a graduate student joined the lab of a prominent researcher in Australia, investigating new therapies for Parkinson’s. A few months later, everything fell apart.

In September 2013, the University of Queensland (UQ) announced it was retracting one of the lab’s papers, returning the money used to fund the research and launching a fraud investigation.  Since then, the scandal has grown to the point where the lead researcher and his co-author have been convicted of fraud in an Australian court.  

Now, the graduate student is fighting back. After losing her research project and being escorted off campus for allegedly erratic behavior, she has appealed to UQ to reimburse her for tens of thousands of dollars in tuition, and is now awaiting a verdict from a government ombudsman. The graduate student goes by “Dominique,” which is not her real name; Retraction Watch is keeping her identity confidential to protect her privacy. Read the rest of this entry »

Written by trevorlstokes

November 22nd, 2016 at 9:30 am

Hospitalization of participant in child psych study prompted misconduct inquiry: Letter

without comments

Mani Pavuluri

Mani Pavuluri

The adverse event that prompted the University of Illinois at Chicago to shutter three trials by a child psychiatrist occurred when one of the study subjects was hospitalized.

According to a 2013 letter obtained by Retraction Watch through a public records request, the subject was admitted to a 10-day inpatient treatment program after exhibiting an increase in irritability and aggression, which prompted researcher Mani Pavuluri to notify the university’s Institutional Review Board (IRB) in January of that year. As a result, the university halted three studies by Pavuluri, sent out letters to 350 research subjects, and launched a misconduct inquiry.

Here’s how the document describes the event (with some details blacked out): Read the rest of this entry »

Written by Alison McCook

October 31st, 2016 at 11:30 am

Despite retraction, antipsychotics still effective, safe for dementia, says author

without comments

alzheimers-research-and-therapyResearchers have retracted a systematic review that suggested that antipsychotic drugs are effective and safe for patients with symptoms of dementia — but claim their re-analysis of the updated data still comes to the same conclusions.

According to the retraction notice in Alzheimer’s Research and Therapy, some participants were incorrectly included twice in the meta-analysis. 

The corresponding authors recently lost another paper for an entirely different reason — earlier this year, we reported on a retraction in Annals of Neurology for Jin-Tai Yu and Lan Tanaffiliated with the Ocean University of China, Qingdao University, and Nanjing Medical University in China. The authors pulled that paper after appearing to pass off others’ data as their own.

Here’s the retraction notice for the review, issued earlier this year: Read the rest of this entry »